Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of melatonin on sleep quality in post-coronary care unit patients
IRCT2017081010340N18Phase 2Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of melatonin in sleep disorder, sponsored by Golestan University of Medical Sciences. Primary endpoint: Sleep quality. Started May 2017; status: completed.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on IRCT2017081010340N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017081010340N18.